HOME › DRUGS › DAUNORUBICIN;CYTARABINE
ACTIVE SUBSTANCE / INN

DAUNORUBICIN;CYTARABINE

Brand name(s): Vyxeos liposomal (previously Vyxeos)
EMA LISTED
AUTHORISED
Leukemia, Myeloid, Acute
ACTIVE SUBSTANCE
Daunorubicin;Cytarabine
REGULATORS
EMA
SPONSORS / MAH
Jazz Pharmaceuticals Ireland Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Vyxeos liposomal (previously Vyxeos)Jazz Pharmaceuticals Ireland LimitedAuthorised23/08/2018Leukemia, Myeloid, Acute

FULL INTELLIGENCE ON DAUNORUBICIN;CYTARABINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →